<?xml version="1.0" encoding="UTF-8"?>
<ref id="B260-pharmaceuticals-12-00147">
 <label>260.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tian</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Zi</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Yan</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Guan</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Ong</surname>
    <given-names>H.H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>H3N2 influenza virus infection enhances oncostatin M expression in human nasal epithelium</article-title>
  <source>Exp. Cell Res.</source>
  <year>2018</year>
  <volume>371</volume>
  <fpage>322</fpage>
  <lpage>329</lpage>
  <pub-id pub-id-type="doi">10.1016/j.yexcr.2018.08.022</pub-id>
  <?supplied-pmid 30142324?>
  <pub-id pub-id-type="pmid">30142324</pub-id>
 </element-citation>
</ref>
